2016
DOI: 10.1016/j.braindev.2015.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Functional outcomes in Rett syndrome

Abstract: Aim To relate functional outcomes to mutation type and age at evaluation in patients with Rett syndrome (RTT). Method We identified 96 RTT patients with mutations in the MECP2 (methyl-CpG-binding protein 2) gene. Chart analysis, clinical evaluation, and functional measures were completed. Results Among 11 mutation groups, a statistically significant group effect of mutation type was observed for self-care, upper extremity function, and mobility, on standardized measures administered by Occupational and Phy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0
3

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 20 publications
(22 reference statements)
1
5
0
3
Order By: Relevance
“…This mutation is the second most common mutation located within the methylated-CpG-binding domain of the MECP2 protein and is causative in 4% of all patients with MECP2-related disorders [ 10 ]. In line with previous reports, patient #15 could speak single words, did not show any regression and did not develop microcephaly [ 11 ]. She met neither main nor supportive criteria for classical or even atypical Rett syndrome.…”
Section: Resultssupporting
confidence: 92%
“…This mutation is the second most common mutation located within the methylated-CpG-binding domain of the MECP2 protein and is causative in 4% of all patients with MECP2-related disorders [ 10 ]. In line with previous reports, patient #15 could speak single words, did not show any regression and did not develop microcephaly [ 11 ]. She met neither main nor supportive criteria for classical or even atypical Rett syndrome.…”
Section: Resultssupporting
confidence: 92%
“…For instance, the relatively common p.Arg133Cys mutation has been shown to be of least severity compared with other common MECP2 mutations. The nonsense mutations p.Arg168 * and p.Arg255 * seen in young children are observed to be among the most clinically severe (Neul et al., ; Pidcock et al., ). Early truncating and large deletion mutations in MECP2 gene have been implicated in delayed early development and inability to walk.…”
Section: Discussionmentioning
confidence: 99%
“…La etiología de RTT se ha establecido por alteraciones en el gen MECP2 localizado en la región Xq28p, cuya estruc-tura está compuesta por cuatro exones como se evidencia en la figura 1 y codifica una proteína de unión a metil CpG 2 (55). Una región de 80 aminoácidos llamada dominio de unión a metil CpG (MBD) cerca del N-terminal pareciera ser suficiente para enlazar el ADN metilado in vitro e in vivo.…”
Section: Diagnóstico Molecularunclassified
“…con RTT en RettBASE (R106W, R133C, T158M, R168X, R255X, R270X, R294X, y R306C) (52,55). De todas maneras, se estima que el MECP2 está mutado en el 80-90 % de las pacientes con RTT clásico así como en el 40 % con RTT atípico, por lo que el diagnóstico debe ser esencialmente clínico ante la existencia de otros genes probablemente asociados, relacionándose por ejemplo, las variantes convulsiva temprana y congénita con mutaciones en los genes CDKL5 y FOXG1, respectivamente (5,37,59).…”
Section: Diagnóstico Molecularunclassified
See 1 more Smart Citation